HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

SYK

Stryker Corporation (S&P 500)

Healthcare — Medical Devices

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Buy 1.6 / 5 26 analysts
$346.60
+$9.86 (+2.93%)
Target: $387.04 (11.7%)
Sign in to add SYK to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$132.87B
P/E Ratio (TTM)40.07
Forward P/E20.72
EPS (TTM)$8.65
Dividend Yield1.05%
Profit Margin13.21%
Revenue Growth2.60%
ROE15.20%
Debt/Equity66.30
Recommendation Buy 1.6
Analyst Target$387.04
Analysts26
Indexes S&P 500

Technical Indicators

RSI (14)59.5
Beta0.78
SMA 20$323.93
SMA 40$316.26
52-Week High$403.92
52-Week Low$281.00
50-Day Avg$314.61
200-Day Avg$343.69
Avg Volume$2.79M
Volume$2.52M

Performance Analysis

BULLISH

SYK shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 53% of its 52-week range.
+ RSI at 59.5 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
- P/E of 40.1 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 2.6% year-over-year.
+ Wall Street consensus is "Buy" from 26 analysts.
+ Average analyst target of $387.04 implies 11.7% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:01 UTC

Back to Screener Export Report